Two Sigma Investments
DGX icon

Two Sigma Investments’s Quest Diagnostics DGX Stock Holding History

Two Sigma Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,800
Closed -$2.21M – 3070
2021
Q4 		$2.21M Buy
12,800
+600
+5% +$91.3K ﹤0.01% 1837
2021
Q3 		$1.77M Buy
12,200
+300
+3% +$43.9K ﹤0.01% 2103
2021
Q2 		$1.57M Buy
11,900
+3,400
+40% +$445K ﹤0.01% 2093
2021
Q1 		$1.09M Buy
+8,500
New +$1.05M ﹤0.01% 2228
2020
Q3 		– Sell
-3,900
Closed -$444K – 3185
2020
Q2 		$444K Buy
+3,900
New +$414K ﹤0.01% 2085
2020
Q1 		– Sell
-5,900
Closed -$630K – 3256
2019
Q4 		$630K Sell
5,900
-800
-12% -$83.4K ﹤0.01% 2602
2019
Q3 		$717K Sell
6,700
-9,900
-60% -$1.02M ﹤0.01% 2258
2019
Q2 		$1.69M Buy
+16,600
New +$1.6M 0.01% 1556
2018
Q4 		– Sell
-3,400
Closed -$367K – 3086
2018
Q3 		$367K Sell
3,400
-600
-15% -$65.8K ﹤0.01% 2646
2018
Q2 		$440K Sell
4,000
-38,800
-91% -$4.04M ﹤0.01% 2727
2018
Q1 		$4.29M Buy
+42,800
New +$4.38M 0.01% 1041
2016
Q4 		– Sell
-7,600
Closed -$643K – 3175
2016
Q3 		$643K Buy
+7,600
New +$638K ﹤0.01% 2281
2015
Q4 		– Sell
-17,000
Closed -$1.04M – 2726
2015
Q3 		$1.04M Buy
+17,000
New +$1.19M 0.01% 1173

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Two Sigma Investments's DGX Position: Q1 2026 in Review

Two Sigma Investments sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 47,984 shares — an estimated $8.33M sold.

Two Sigma Investments first reported a position in DGX in Q4 2013 and held it in 33 quarters. The position peaked at $95.7M in Q4 2018. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Two Sigma Investments reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 47,984 Quest Diagnostics shares in Q1 2026, an estimated $8.33M.
  • Two Sigma Investments first reported a position in Quest Diagnostics in Q4 2013 and held it in 33 quarters.
  • Two Sigma Investments's Quest Diagnostics position peaked at $95.7M in Q4 2018.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.